Annual Accounts Receivable
$7.95B$986.18M+14.15%
Summary
- Current Value
- As of today, GSK annual accounts receivable is $7.95B, up +14.15% on
- Historical Performance
- GSK annual accounts receivable is up +21.27% over the past 3 years, up +4.85% over the past 5 years
- All-Time High Comparison
- GSK annual accounts receivable is currently -14.21% below its historical high of $9.27B set on
- 3-Year Low Comparison
- GSK annual accounts receivable is +21.27% above its 3-year low of $6.56B reached on an earlier date
- Sector Comparison
- GSK annual accounts receivable is higher than 97.60% of companies in Healthcare sector
Annual Accounts Receivable Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Accounts Receivable | $7.95B | +14.2% | +21.3% | +4.8% | +6.5% | |
| Quarterly Accounts Receivable | $10.92B | +2.2% | +4.8% | +5.3% | +19.0% | |
| Price | $50.33 | +6.9% | +44.7% | +13.5% | +11.1% | |
| Annual Accounts Payable | $4.75B | +9.7% | +2.2% | -20.2% | +41.9% | |
| Annual Current Assets | $23.55B | +10.6% | -5.7% | -14.9% | -6.2% | |
| Annual Revenue | $43.05B | +7.4% | +19.2% | -1.5% | -1.8% | |
| Annual Net Income | $8.29B | +119.8% | +36.7% | +1.2% | +189.8% | |
| Annual Cash & Cash Equivalents | $4.58B | -6.0% | -51.6% | -47.4% | -53.8% |
Annual Accounts Receivable Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $7.95B | at high | |
| 5Y | $8.46B | -6.0% | |
| All | $9.27B | -14.2% |
Annual Accounts Receivable Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $6.56B | N/A | +21.3% |
| 5Y | $6.56B | +21.3% | |
| All | $381.10M | +1986.9% |
Annual Accounts Receivable History
FAQ
- What is the current annual accounts receivable of GSK?
- As of today, GSK annual accounts receivable is $7.95B
- What is 1-year change in GSK annual accounts receivable?
- GSK annual accounts receivable is up +14.15% year-over-year
- What is 3-year change in GSK annual accounts receivable?
- GSK annual accounts receivable is up +21.27% over the past 3 years
- How far is GSK annual accounts receivable from its all-time high?
- GSK annual accounts receivable is currently -14.21% below its historical high of $9.27B set on December 31, 2007
- How does GSK annual accounts receivable rank versus sector peers?
- GSK annual accounts receivable is higher than 97.60% of companies in Healthcare sector
- When is GSK next annual earnings release?
- The next annual earnings release for GSK is on
Annual Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
Quarterly Accounts Receivable
$10.92B$696.06M+6.81%
Summary
- Current Value
- As of today, GSK quarterly accounts receivable is $10.92B, up +6.81% on
- Historical Performance
- GSK quarterly accounts receivable is up +2.23% year-over-year, up +4.75% over the past 3 years
- All-Time High Comparison
- GSK quarterly accounts receivable is currently at its all-time high
- 3-Year Low Comparison
- GSK quarterly accounts receivable is +56.79% above its 3-year low of $6.97B reached on
- Sector Comparison
- GSK quarterly accounts receivable is higher than 98.10% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Accounts Receivable | $10.92B | +6.8% | +2.2% | +4.8% | +5.3% | |
| Annual Accounts Receivable | $7.95B | – | +14.2% | +21.3% | +4.8% | |
| Price | $50.33 | -3.5% | +6.9% | +44.7% | +13.5% | |
| Quarterly Accounts Payable | $20.77B | +9.1% | -1.6% | +9.2% | +1.1% | |
| Quarterly Current Assets | $23.77B | +2.0% | -1.0% | -8.3% | -3.4% | |
| Quarterly Revenue | $11.94B | +5.8% | +3.6% | +15.8% | +30.8% | |
| Quarterly Net Income | $2.29B | +208.4% | -20.8% | +17.9% | +75.6% | |
| Quarterly Cash & Cash Equivalents | $3.93B | -4.5% | -11.6% | -51.8% | -16.9% |
Quarterly Accounts Receivable Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $10.92B | at high | |
| 3Y | $10.92B | at high | |
| 5Y | $10.92B | at high | |
| All | $10.92B | at high |
Quarterly Accounts Receivable Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $7.95B | +37.4% | |
| 3Y | $6.97B | +56.8% | |
| 5Y | $6.56B | +66.6% | |
| All | $381.10M | +2766.4% |
Quarterly Accounts Receivable History
FAQ
- What is the current quarterly accounts receivable of GSK?
- As of today, GSK quarterly accounts receivable is $10.92B
- What is GSK quarterly accounts receivable most recent change?
- GSK quarterly accounts receivable was up +6.81% on September 30, 2026
- What is 1-year change in GSK quarterly accounts receivable?
- GSK quarterly accounts receivable is up +2.23% year-over-year
- How far is GSK quarterly accounts receivable from its all-time high?
- GSK quarterly accounts receivable is currently at its all-time high
- How does GSK quarterly accounts receivable rank versus sector peers?
- GSK quarterly accounts receivable is higher than 98.10% of companies in Healthcare sector
- When is GSK next earnings release?
- The next earnings release for GSK is on
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
Data Sources & References
- GSK Official Website www.gsk.com
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk